1. Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation. (June 2020) Authors: Athauda, Avani; Fong, Caroline; Lau, David K.; Javle, Milind; Abou-Alfa, Ghassan K.; Morizane, Chigusa; Steward, Keith; Chau, Ian Journal: Cancer treatment reviews Issue: Volume 86(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Do investigational MET inhibitors have potential for the treatment of gastric cancer?. (3rd April 2019) Authors: Athauda, Avani; Chau, Ian Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 4(2019) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Emerging precision therapies for gastric cancer. Issue 4 (3rd July 2020) Authors: Cartwright, Elizabeth; Athauda, Avani; Chau, Ian Journal: Expert review of precision medicine and drug development Issue: Volume 5:Issue 4(2020) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03). (September 2020) Authors: Athauda, Avani; Nankivell, Matthew; Langley, Ruth E.; Alderson, Derek; Allum, William; Grabsch, Heike I.; Starling, Naureen; Chau, Ian; Cunningham, David Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Integrative molecular analysis of colorectal cancer and gastric cancer: What have we learnt?. (February 2019) Authors: Athauda, Avani; Segelov, Eva; Ali, Zohra; Chau, Ian Journal: Cancer treatment reviews Issue: Volume 73(2019) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Neoadjuvant and adjuvant multimodality therapies in resectable esophagogastric adenocarcinoma. (24th July 2021) Authors: Lau, David K.; Athauda, Avani; Chau, Ian Journal: Expert opinion on pharmacotherapy Issue: Volume 22:Number 11(2021) Page Start: 1429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging. (14th October 2016) Authors: Khan, Khurum; Athauda, Avani; Aitken, Katharine; Cunningham, David; Watkins, David; Starling, Naureen; Cook, Gary J.; Kalaitzaki, Eleftheria; Chau, Ian; Rao, Sheela Journal: Oncologist Issue: Volume 21:Number 12(2016) Page Start: 1502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography‐Computed Tomography Imaging. (14th October 2016) Authors: Khan, Khurum; Athauda, Avani; Aitken, Katharine; Cunningham, David; Watkins, David; Starling, Naureen; Cook, Gary J.; Kalaitzaki, Eleftheria; Chau, Ian; Rao, Sheela Journal: Oncologist Issue: Volume 21:Number 12(2016) Page Start: 1502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗